机译:乙型肝炎核心相关的抗原监测在HBEAG阴性慢性乙型肝炎中的Peginterferon Alfa治疗过程中
Department of Gastroenterology and HepatologyErasmus MC University Medical CenterRotterdam The;
Department of Gastroenterology and HepatologyErasmus MC University Medical CenterRotterdam The;
Department of Gastroenterology and HepatologyErasmus MC University Medical CenterRotterdam The;
Department of Gastroenterology and HepatologyErasmus MC University Medical CenterRotterdam The;
Department of Internal Medicine Gastroenterology and HepatologyMedical University of ViennaVienna;
Cerrahpasa Medical FacultyIstanbul Turkey;
Department of GastroenterologyYuksek Ihtisas HospitalAnkara Turkey;
Division of Gastroenterohepatology Department of Internal Medicine Istanbul Faculty of;
Division of Infectious Diseases and HepatologyWroclaw Medical UniversityWroclaw Poland;
Department of Gastroenterology and HepatologyErasmus MC University Medical CenterRotterdam The;
Department of Gastroenterology and HepatologyErasmus MC University Medical CenterRotterdam The;
Toronto Center for Liver Disease Toronto Western and General HospitalUniversity Health;
Department of Gastroenterology and HepatologyErasmus MC University Medical CenterRotterdam The;
antiviral treatment response; biomarker; hepatitis B; peginterferon Alfa‐2a;
机译:乙型肝炎核心相关的抗原监测在HBEAG阴性慢性乙型肝炎中的Peginterferon Alfa治疗过程中
机译:II期和III期研究对聚乙二醇干扰素α-2a治疗乙型肝炎e抗原(HBeAg)阳性和HBeAg阴性的慢性乙型肝炎患者的长期随访
机译:我们是否准备好使用乙肝表面抗原水平指导HBeAg阴性慢性乙肝患者的聚乙二醇干扰素治疗?
机译:丙型肝炎,乙型肝炎和慢性肝炎的治疗和原因
机译:HBeAg阴性慢性乙型肝炎病毒感染的病毒突变和自然病程。
机译:基因型特异性基线评分可预测乙型肝炎e抗原阴性的慢性乙型肝炎对聚乙二醇干扰素al-2a的治疗后反应
机译:乙型肝炎核心相关的抗原监测在HBEAG阴性慢性乙型肝炎的PEGINTERFEREN ALFA治疗过程中